SELDI ProteinChip array in oncoproteomic research.
Research into the causes, early detection and treatment of cancers is a primary focus of the health care industry and proteomic-based methodologies are providing an increasingly important role in addressing these issues. The ProteinChip Array technology forms the basis of a clinical proteomics platform designed to expedite the discovery, validation, and characterization of cancer biomarkers at all stages of cancer progression. Being able to detect cancer progression early in turn allows for the possibility of more effective treatment. This short review serves to introduce the technology by highlighting specific examples related to cancer biomarker discoveries.
Yip
Tai-Tung
TT
Ciphergen Biosystems Inc, 6611 Dumbarton Circle, Fremont, CA 94555, USA. tyip@ciphergen.com
Lomas
Lee
L
D014408:Biomarkers, Tumor / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D011379:Prognosis; D040081:Protein Array Analysis
D014408:Biomarkers, Tumor